These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33179792)

  • 1. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
    Liu A; Dhaliwal N; Upreti H; Kasmani J; Dane K; Moliterno A; Braunstein E; Brodsky R; Chaturvedi S
    Transfusion; 2021 Jan; 61(1):266-273. PubMed ID: 33179792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
    Li A; Khalighi PR; Wu Q; Garcia DA
    J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre.
    Tufano A; Polimeno M; Matani B; Cardillo G; Capasso F; Mormile R; Paladino F; Di Minno G
    Blood Transfus; 2023 Jul; 21(4):345-349. PubMed ID: 35969133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea.
    Park SH; Kim HK; Jeong J; Lee SH; Lee YJ; Kim YJ; Jo JC; Lim JH
    Ann Lab Med; 2023 Sep; 43(5):485-492. PubMed ID: 37080750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.
    Tau J; Fernando LP; Munoz MC; Poh C; Krishnan VV; Dwyre DM
    Ther Apher Dial; 2023 Feb; 27(1):136-145. PubMed ID: 35501999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified PLASMIC score including the lactate dehydrogenase/the upper limit of normal ratio more accurately identifies Chinese thrombotic thrombocytopenic purpura patients than the original PLASMIC score.
    Zhao N; Zhou L; Hu X; Sun G; Chen C; Fan X; Zhou S; Tao X; Liu H; Zheng C
    J Clin Apher; 2020 Apr; 35(2):79-85. PubMed ID: 31724781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores.
    Baysal M; Hindilerden F; Ümit EG; Demir AM; Keklik Karadağ F; Saydam G; Akpınar S; Turgut B; Özkocaman V; Özkalemkaş F; Çiftçiler R; Özlü C; Demircioğlu S; İpek Y; Diz Küçükkaya R
    Turk J Haematol; 2023 Dec; 40(4):251-257. PubMed ID: 37791641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.
    Bendapudi PK; Hurwitz S; Fry A; Marques MB; Waldo SW; Li A; Sun L; Upadhyay V; Hamdan A; Brunner AM; Gansner JM; Viswanathan S; Kaufman RM; Uhl L; Stowell CP; Dzik WH; Makar RS
    Lancet Haematol; 2017 Apr; 4(4):e157-e164. PubMed ID: 28259520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Diagnostic Scores in Thrombotic Microangiopathy Patients in the Intensive Care Unit: A Monocentric Study.
    Mariotte E; Zafrani L; Fadlallah J; Galicier L; Ghrenassia E; Kerhuel L; Calvet L; Jong A; Lemiale V; Valade S; Joly BS; Stepanian A; Azoulay E; Darmon M
    Thromb Haemost; 2021 Nov; 121(11):1427-1434. PubMed ID: 33512705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada.
    Wynick C; Britto J; Sawler D; Parker A; Karkhaneh M; Goodyear MD; Sun HL
    Thromb Res; 2020 Dec; 196():335-339. PubMed ID: 32977133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Different Scoring Systems for the Diagnosis of Thrombotic Microangiopathies.
    Yilmaz S; Cenelİ O; Tekinalp A
    J Coll Physicians Surg Pak; 2023 May; 33(5):539-543. PubMed ID: 37190689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry.
    Hassan S; Westwood JP; Ellis D; Laing C; Mc Guckin S; Benjamin S; Scully M
    Br J Haematol; 2015 Dec; 171(5):830-5. PubMed ID: 26359646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: A systematic review and meta-analysis.
    Paydary K; Banwell E; Tong J; Chen Y; Cuker A
    Transfusion; 2020 Sep; 60(9):2047-2057. PubMed ID: 32757237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura.
    Reeves HM; Maitta RW
    Thromb Res; 2022 Jul; 215():30-36. PubMed ID: 35617796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of 61 patients with thrombotic thrombocytopenic purpura].
    Shi MJ; Gao WB; Huang WF; Zhu JH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 53(1):210-214. PubMed ID: 33550359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
    Scully M; Cataland S; Coppo P; de la Rubia J; Friedman KD; Kremer Hovinga J; Lämmle B; Matsumoto M; Pavenski K; Sadler E; Sarode R; Wu H;
    J Thromb Haemost; 2017 Feb; 15(2):312-322. PubMed ID: 27868334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.